| Basics |
Cytokinetics, Incorporated
Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
|
| IPO Date: |
May 1, 2004 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$6.34B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.39 | 2.82%
|
| Avg Daily Range (30 D): |
$0.94 | 2.45%
|
| Avg Daily Range (90 D): |
$0.80 | 2.24%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.56M |
| Avg Daily Volume (30 D): |
1.83M |
| Avg Daily Volume (90 D): |
1.6M |
| Trade Size |
| Avg Trade Size (Sh.): |
106 |
| Avg Trade Size (Sh.) (30 D): |
63 |
| Avg Trade Size (Sh.) (90 D): |
62 |
| Institutional Trades |
| Total Inst.Trades: |
7,226 |
| Avg Inst. Trade: |
$3.26M |
| Avg Inst. Trade (30 D): |
$3.52M |
| Avg Inst. Trade (90 D): |
$3.09M |
| Avg Inst. Trade Volume: |
.09M |
| Avg Inst. Trades (Per Day): |
4 |
| Market Closing Trades |
| Avg Closing Trade: |
$6.65M |
| Avg Closing Trade (30 D): |
$10.35M |
| Avg Closing Trade (90 D): |
$8.42M |
| Avg Closing Volume: |
172.33K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
|
$-1.12
|
$-1.36
|
|
Diluted EPS
|
|
$-1.12
|
$-1.36
|
|
Revenue
|
$
|
$ 66.77M
|
$ 1.58M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$
|
$ -134.37M
|
$ -161.38M
|
|
Operating Income / Loss
|
$
|
$ -111.51M
|
$ -155.63M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$
|
$ 2.5M
|
$ -21.18M
|
|
PE Ratio
|
|
|
|
|
|
|
